IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
Abstract Blockade of NKG2A/HLA-E interaction is a promising strategy to unleash the anti-tumor response. Yet the role of NKG2A+ CD8 T cells in the anti-tumor response and the regulation of NKG2A expression on human tumor-infiltrating T cells are still poorly understood. Here, by performing CITE-seq...
Saved in:
| Main Authors: | Olivier Fesneau, Kimberly A. Samson, Wesley Rosales, Bretton Jones, Tarsem Moudgil, Bernard A. Fox, Venkatesh Rajamanickam, Thomas Duhen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54420-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
by: Trinidad Hernández-Caselles, et al.
Published: (2019-01-01) -
CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01) -
Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.
by: Syeda S Hassan, et al.
Published: (2013-01-01) -
Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL
by: Jennifer Bolsée, et al.
Published: (2025-05-01) -
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01)